Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of October 12, 2026, ICCC trades at $9.80 with a market cap of $89.01M and a P/E ratio of 121.85. ICCC moved +2.55% today. Year to date, ICCC is +56.10%; over the trailing twelve months it is +41.18%. Its 52-week range spans $4.28 to $12.10. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $9.80 |
| Market Cap | $89.01M |
| P/E Ratio | 121.85 |
| EPS |
| $0.08 |
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $12.10 |
|---|
| 52-Week Low | $4.28 |
|---|
| Volume | 8.50K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $30.68M |
|---|
| Net Income | $787.37K |
|---|
| Gross Margin | 40.32% |
|---|
ICCC analyst coverage data. Average price target: $0.00.